Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conferen

Business Wirevia The Motley Fool
Updated

Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conference Call on February 28

BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NAS: CLVS) will announce its fourth quarter/year end 2012 financial results on Thursday, February 28, 2013, after the close of the U.S. financial markets. Clovis' senior management will host a conference call and live audio webcast on Thursday, February 28, at 4:30 p.m. ET to discuss the company's results in greater detail.

The conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com. A replay of the webcast will be available for 30 days.


About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California, and Cambridge, UK.



Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS:

The article Clovis Oncology to Announce Fourth Quarter/Year End 2012 Financial Results and Host Webcast Conference Call on February 28 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement